Breakdown | |||||
TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
59.64B | 54.49B | 48.38B | 45.32B | 41.04B | 42.93B | Gross Profit |
14.63B | 13.68B | 12.24B | 11.46B | 9.79B | 9.35B | EBIT |
2.03B | 2.13B | 2.27B | 2.51B | 2.06B | 2.02B | EBITDA |
2.45B | 2.75B | 2.69B | 2.97B | 2.69B | 2.08B | Net Income Common Stockholders |
576.00M | 1.21B | 1.18B | 1.48B | 852.00M | 769.00M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
7.99B | 7.47B | 7.01B | 7.29B | 6.63B | 6.07B | Total Assets |
35.39B | 33.38B | 30.72B | 27.50B | 24.69B | 25.04B | Total Debt |
3.19B | 2.87B | 2.73B | 2.02B | 2.43B | 3.00B | Net Debt |
-4.81B | -4.60B | -4.28B | -5.26B | -4.20B | -3.07B | Total Liabilities |
21.79B | 20.16B | 18.23B | 16.11B | 14.82B | 15.81B | Stockholders Equity |
11.63B | 11.41B | 10.54B | 9.44B | 7.98B | 7.57B |
Cash Flow | Free Cash Flow | ||||
0.00 | 1.36B | 1.34B | 1.75B | 1.65B | 2.96B | Operating Cash Flow |
0.00 | 1.52B | 1.59B | 2.23B | 1.92B | 3.09B | Investing Cash Flow |
0.00 | -268.00M | -2.05B | -725.00M | -112.00M | -413.00M | Financing Cash Flow |
0.00 | -813.00M | 56.00M | -871.00M | -1.24B | -338.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | ¥10.36B | 10.94 | 1.74% | 13.00% | -17.83% | ||
76 Outperform | ¥11.10B | 13.10 | 2.33% | -2.46% | 13.79% | ||
71 Outperform | ¥4.26B | 10.22 | ― | 15.58% | 38.21% | ||
69 Neutral | ¥8.35B | 11.38 | 4.02% | 3.93% | 1.66% | ||
68 Neutral | ¥9.28B | 24.32 | 1.32% | 4.70% | 35.62% | ||
62 Neutral | ¥15.37B | 11.39 | 3.47% | -8.55% | -14.28% | ||
61 Neutral | $14.60B | 5.95 | -4.32% | 3.69% | 2.76% | -30.49% |